Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Fresenius Se & CO (FSNUF)

Fresenius Se & CO (FSNUF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Fresenius Se & CO

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Fresenius SE & Co KGaA is a health care company. It offers products and services for dialysis, hospitals, and outpatient medical care. It also manage projects and provide services for hospitals and other health care facilities worldwide. The Company's business segments are: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. Fresenius Medical Care offers products and services for patients with chronic kidney failure. Fresenius Kabi specializes in infusion therapies, intravenously administered drugs (IV drugs), and clinical nutrition. The company is also a supplier of medical devices and products in the area of transfusion technology. Fresenius Helios operated a total of 74 hospitals with more than 23,000 beds in Germany. Fresenius Vamed manages projects and provides services for hospitals and other health care facilities. The Company operates in about 80 countries through its subsidiaries.

Key Statistics

Overview:

Short Interest, K 966
Short Float 0.00%
Days to Cover 999.99
Short Volume Ratio 1.00

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ 0 K

Growth:

1-Year Return 61.30%
3-Year Return 19.62%
5-Year Return 0.00%

Per-Share Information:

Next Earnings Date N/A
Next Ex-Dividends Date 05/19/14
Dividend Payable Date 05/19/14
Dividend Payout Ratio 0.00%

FSNUF Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % N/A
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Cash Flow 11.30
Price/Book 1.78
Book Value/Share N/A
Interest Coverage N/A
60-Month Beta N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar